"In light of the Company’s inability to presently predict the duration of the stop ship, the Company believes that it will be ...

Hologic said it expects to close an unspecified number of international facilities as it discontinues certain products and shifts strategy in one of its diagnostics businesses. The women’s ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. | Hologic put forward another study that bolsters the use ...

Hologic stock (NASDAQ: HOLX) has rallied around 83% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $53 after falling to a low of $29 in late March as a rapid increase ...

The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Marlborough medical device manufacturer Hologic is anticipating to make an unspecified number of layoffs at international locations this year amid a restructuring of its diagnostics division, as sales ...

Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams ...

In the fourth quarter of fiscal 2025, Diagnostics revenues increased 1.5% in constant currency (CC), driven by higher core ...

Between 2016 and 2019, researchers at a top-tier medical facility conducted 7,500 digital breast tomosynthesis (3D ...